Is a complete IVA research report available?

No complete published report is available for Inventiva S.A. (IVA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Inventiva S.A. (IVA)

NASDAQ: IVA · USD

$4.46

-0.05 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IVA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1B
Revenue (ttm)	7.9M
Net income (ttm)	-415.8M
EPS (ttm)	-$2.23
Shares out	207.7M
Volume	667,373
Beta	0.89
Price target	$15.1	+239.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.9M
Net income (ttm): -415.8M
EPS (ttm): -$2.23
Market cap: 1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IVA indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

EUR

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001756594
Company name	Inventiva S.A.
Country	France
Country code	US
Cusip	46124U107
Employees	77
Employees Change	-41%
Employees Change Percent	-34.75
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-07-10
Isin	US46124U1079
Last refreshed	2026-07-25
Market cap	$1B
Market cap category	Small-Cap
Price	$4.46
Price currency	USD
Rev Per Employee	103,094.04x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2834
Symbol	IVA
Website	https://inventivapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.46%
EV Sales Forward	185.54x
EV/Sales	148.25x
FCF yield	-11.64%
P/S ratio	129.46x
PS Forward	162.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,779.12%
EBITDA Margin	-1,738.46%
Gross margin	99.67%
Gross Profit	$7.9M
Gross Profit Growth	-48.44%
Gross Profit Growth Q	-93.13%
Gross Profit Growth3 Y	-26.62%
Gross Profit Growth5 Y	8.82%
Net Income	$-415.8M
Net Income Growth Years	0%
Pretax Margin	-5,237.63%
Profit Per Employee	$-5.4M
ROA	-45.08
Roa5y	-46.67
ROCE	-79.38
ROIC	-59.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	34.36%
Cagr3y	3.69%
Cagr5y	-20.29%
EPS Growth Years	1
Revenue Growth	-52.03x
Revenue Growth Q	-89.87x
Revenue Growth Years	0x
Revenue Growth3 Y	-27.92x
Revenue Growth5 Y	5.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.04
Assets	$293M
Cash	$117.2M
Current Assets	$278.1M
Current Liabilities	$88M
Debt	$271.1M
Equity	$-33.5M
Interest Coverage	-4.07
Liabilities	$326.4M
Long Term Assets	$14.8M
Long Term Liabilities	$238.4M
Net Cash	$-153.9M
Net Cash By Market Cap	$-14.97
Tangible Book Value	$-33.7M
Tangible Book Value Per Share	$-0.17
WACC	9.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.16
Net Working Capital	$116.9M
Quick ratio	1.41
Working Capital	$196.2M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-212.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	34.34%
200-day SMA	5.08
3Y total return	11.5%
50-day SMA	4.33
50-day SMA vs 200-day SMA	50under200
5Y total return	-67.82%
All Time High	19.06
All Time High Change	-76.61%
All Time High Date	2021-01-21
All Time Low	1.53
All Time Low Change	191.5%
All Time Low Date	2024-09-26
ATR	0.26
Beta	0.89
Ch YTD	-4.09
High	4.55
High52	7.98
High52 Date	2025-10-28
High52ch	-44.13%
Low	4.38
Low52	2.85
Low52 Date	2025-07-25
Low52ch	56.27%
Ma50ch	3.12%
Premarket Change Percent	-2.66
Premarket Price	$4.39
Premarket Volume	101
Price vs 200-day SMA	-12.22%
RSI	55.04
RSI Monthly	49.81
RSI Weekly	45.78
Sharpe ratio	0.73x
Sortino ratio	1.12
Total Return	-212.49%
Tr YTD	-4.09
Tr1m	20.22%
Tr1w	-3.46%
Tr3m	-14.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	9
Analyst Price Target Top	$17.14
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.66
Earnings Revenue Estimate	6,000,000x
Earnings Revenue Estimate Growth	-39.73x
Operating Income	$-156M
Operating margin	-1,965.5
Price target	$15.13
Price Target Change	$239
Price Target Change Top	$284

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	180,983,726%
Float Percent	87.13%
Net Borrowing	-6,803,572.4
Shares Insiders	4.18%
Shares Institutions	52.97%
Shares Out	207,707,475
Shares Qo Q	143.26%
Shares Yo Y	212.49%
Short Ratio	1.12
Short Shares	0.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-151M
Average Volume	1,418,007.6x
Bv Per Share	-0.17
CAPEX	$-290,008
Ch1m	20.22
Ch1w	-3.46
Ch1y	34.34
Ch3m	-14.4
Ch3y	11.5
Ch5y	-67.82
Ch6m	-37.62
Change	-1.11%
Change From Open	0.45
Close	4.51
Days Gap	-1.55
Depreciation Amortization	441,435.8
Dollar Volume	2,976,483.6
Earnings Date	2026-03-30
Earnings Time	amc
EBIT	$-160.4M
EBITDA	$-156.8M
EPS	$-2.23
F Score	3
FCF	$-119.6M
FCF EV Yield	-10.16x
FCF Per Share	$-0.58
Financing CF	283,299,284
Fiscal Year End	December
Founded	2,011
Income Tax	$25,831
Investing CF	-156,376,659
Ipr	-69.03
Iprfo	-70.52
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-08
Ma150	5.25
Ma150ch	-15.11%
Ma20	4.24
Ma20ch	5.26%
Net CF	3,226,488
Next Earnings Date	2026-09-25
Open	4.44
Optionable	Yes
Position In Range	48.48
Post Close	4.46
Postmarket Change Percent	0.11
Postmarket Price	$4.47
Ppne	3,389,271.3
Pre Close	4.51
Price Date	2026-07-24
Relative Volume	0.47x
Revenue	7,938,241x
SBC By Revenue	395.93x
Share Based Comp	31,430,081
Tax By Revenue	0.33x
Tr6m	-37.62%
Volume	667,373
Z Score	-1.98

Inventiva S.A. (IVA)

Coverage state: Market snapshot only — no published research

Generate the first IVA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IVA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IVA

Frequently asked questions